Tidewater Clinical Research/TPW
Welcome,         Profile    Billing    Logout  
 2 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morgan, Franklin
NCT04209543 / 2019-001289-14: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Completed
3
1570
Europe, Canada, US, RoW
Estetrol, Placebo, Progesterone
Estetra, ICON Clinical Research
Vasomotor Symptoms, Menopausal Symptoms
02/24
02/24
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Recruiting
3
160
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
12/24
12/24
NCT05101317: A Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated Pain

Recruiting
2
152
Europe, US, RoW
HMI-115, Placebo
Hope Medicine (Nanjing) Co., Ltd
Endometriosis
12/24
04/25
Rusch, April
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Completed
3
1319
Canada, US
MR-100A-01, Transdermal contraceptive delivery system
Mylan Technologies Inc., Mylan Inc.
Contraception
01/25
01/25
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Recruiting
3
160
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
12/24
12/24
NCT03942419: Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

Terminated
3
438
US
Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic Solution
Eyenovia Inc.
Myopia
10/24
11/24
NCT05096065: Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Recruiting
2
16
US
Leuprolide Oral Tablet - 120 mg - QD- Treatment A, Ovarest® 60 mg, Leuprolide Oral Tablet - 80 mg - QD - Treatment B, Ovarest® 40 mg, Leuprolide Oral Tablet - 60 mg - QD - Treatment C, Leuprolide Oral Tablet - 60 mg - BID - Treatment D, Leuprolide Oral Tablet - 40 mg - BID - Treatment E
Enteris BioPharma Inc., Parexel, Syneos Health
Endometriosis
05/22
05/22
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy

Active, not recruiting
N/A
59
US
Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures
ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Laparoscopic Hysterectomy
06/24
05/25

Download Options